Alto Neuroscience, Inc. ($ANRO)
Filing Information
| Accession Number | 0002009130-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 2, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
404,658
Total Value
$3,884,228.64
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT AND CFO | Common Stock | โ | Sep 29, 2026 | Exercise/Conversion | 56,455 | $2.35 | $132,669.25 | 80,515 | Direct | โ | View Details | |
PRESIDENT AND CFO | Common Stock | โ | Sep 29, 2026 | Exercise/Conversion | 54,375 | $2.35 | $127,781.25 | 134,890 | Direct | โ | View Details | |
PRESIDENT AND CFO | Common Stock | โ | Sep 29, 2026 | Sale | 110,830 | $26.58 | $2,946,149.56 | 24,060 | Direct | โ | View Details | |
PRESIDENT AND CFO | Common Stock | โ | Sep 30, 2026 | Exercise/Conversion | 24,056 | $2.35 | $56,531.60 | 48,116 | Direct | โ | View Details | |
PRESIDENT AND CFO | Common Stock | โ | Sep 30, 2026 | Sale | 23,170 | $25.78 | $597,290.16 | 24,946 | Direct | โ | View Details | |
PRESIDENT AND CFO | Common Stock | โ | Sep 30, 2026 | Sale | 886 | $26.87 | $23,806.82 | 24,060 | Direct | โ | View Details | |
PRESIDENT AND CFO | Employee Stock Option (Right to Buy) | Derivative | Sep 29, 2026 | Exercise/Conversion | 56,455 | $0.00 | $0.00 | 145,874 | Direct | โ | View Details | |
PRESIDENT AND CFO | Employee Stock Option (Right to Buy) | Derivative | Sep 29, 2026 | Exercise/Conversion | 54,375 | $0.00 | $0.00 | 35,625 | Direct | โ | View Details | |
PRESIDENT AND CFO | Employee Stock Option (Right to Buy) | Derivative | Sep 30, 2026 | Exercise/Conversion | 24,056 | $0.00 | $0.00 | 121,818 | Direct | โ | View Details |